Equity
€159,962 from €601,190 in 2006
Equity fell by 73% in 19 years.
FARMA - BOVAN
Lifetime
20 annual accounts with figures on one time axis, 38 filings since 1987peak €205,085 (2012)
-€147▼ €52,516
lowest -€39,504 (2009)
-€18,521▼ €45,273
peak €601,190 (2006)
€159,962▼ 10.4%
€251,664▼ 33.6%
peak 2.9 FTE (2009)
0 FTE
Board7 names since 2015
2 directors and 1 other
Owners5 names in the annual accounts
Documentsfilings and deeds
15-10-202676 days late
2025abbreviated format
Gross margin from €52,370 to -€147Loss of €18,521Debts from €379,030 to €251,664Cash from €14,689 to €308
Key points
from the 2025 annual accountsFilings
38 annual accounts 76 days
Latest accounts filed late: after the legal deadline.
Position in the sector
-€18,521
Lower net result than 84% of companies in retail trade. Sector median €38,016 · 13,231 companies.
Turnover not published (abbreviated format)
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 12,322 companies had the same profile as FARMA - BOVAN has now. Each dot stands for 31 companies, two years later.
90.3%
were still trading
8.5%
stopped another way
0.7%
went bankrupt
Another 0.4% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,331 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 12,322 companies, not a prediction for FARMA - BOVAN. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Director, since 29-11-2023
Director, , since 29-11-2023
- 40%score equity €579,330 (2025) · 2025 annual accounts of
- 40%equity €803,451 (2025) · 2025 annual accounts of
- 20%score equity €1.1m (2025) · 2025 annual accounts of
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0429239351
1 director appointed, 3 resignations
Resignations: , and · Permanent representative: · Appointment: (director) · Gazette deed
Registered office moved within Sint-Niklaas
New registered office: Vijfstraten 209 te 9100 Sint-Niklaas · Previous registered office: Nieuwkerkenstraat 10, 9100 Sint-Niklaas · Board meeting of 11-01-2022 · Gazette deed
New managing director
appointed, resigned · Permanent representative: · General meeting of 20-01-2020 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| FARMA - BOVAN Sint-Niklaas | €411,627 | -€147 | 38.9% | 0 |
| APOTEEK BRICHAU Halle | €263,690 | -€2,567 | 38.9% | 0 |
| MEPHAR Sint-Niklaas | €470,027 | -€822 | 90.6% | - |
| APOTHEEK VAN DENDER Ostend | €239,581 | -€8,121 | 98.4% | 0 |
| PHARMACIE SCHNEIDER - DEPOUHON Frameries | €483,767 | -€137,576 | 93.8% | 0.7 |
| APOTHEEK ATTENHOVEN Landen | €354,841 | -€4,798 | -16.4% | - |
| M.M. - PHARMA Brussels | €504,592 | -€27,099 | 28.5% | - |
These companies have the same main activity as FARMA - BOVAN: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €240,000 and €505,000, founded between 1983 and 2000.
Official details
Source: KBO- Status
- Active since 27-06-1986Normal situation
- Activity
- Retail sale of pharmaceutical productsNACE 47730
- Joint committee
- 313Pharmacies and pricing offices · annual accounts 2022
- Establishment unit
- 2.042.131.1029100 Sint-Niklaas, since 19-03-1992
- Financial year end
- 31 December
- Peppol
- Reachable since 12-01-2026
Insights on FARMA - BOVAN
FARMA - BOVAN files the abbreviated format. That format states no turnover. The gross margin fell from €116,090 in 2006 to -€147 in 2025.
The balance sheet grew most from 2009 to 2011 through fixed assets.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about FARMA - BOVAN
- What is the company number of FARMA - BOVAN?
- The company number of FARMA - BOVAN is 0429.239.351. The VAT number is the same number with BE in front: BE 0429.239.351.
- Where is FARMA - BOVAN based?
- The registered office is at Vijfstraten 209, 9100 Sint-Niklaas.Company details
- What does FARMA - BOVAN do?
- According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
- What is the legal form of FARMA - BOVAN?
- FARMA - BOVAN is a public limited company (NV).
- When was FARMA - BOVAN founded?
- FARMA - BOVAN was founded on 27-06-1986.
- Is FARMA - BOVAN still active?
- Yes, FARMA - BOVAN is an active enterprise in the KBO register.
- How many employees does FARMA - BOVAN have?
- FARMA - BOVAN had an average of 1 full-time equivalents in financial year 2021, according to the filed annual accounts.Financials
- Which joint committee does FARMA - BOVAN fall under?
- In its 2022 annual accounts, FARMA - BOVAN states joint committee 313 (Pharmacies and pricing offices).
- What is the turnover of FARMA - BOVAN?
- The annual accounts for financial year 2025 state no turnover. The abbreviated format does not require it.
- Is FARMA - BOVAN profitable?
- In financial year 2025, FARMA - BOVAN made a loss of €18,521.
- Where can I find the annual accounts of FARMA - BOVAN?
- FARMA - BOVAN filed 38 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of FARMA - BOVAN due?
- FARMA - BOVAN must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check See which support similar companies received that this one did not.Subsidies Compare this company with its sector.Sector benchmark
See how customers, suppliers and banks see your own company and what to improve first.